Clinical trials: Psychotic Episode

Schizophrenia

A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode

• Completed
• Age: 17 to 47 years
• Phase 4
• Pill or oral medicine
• Injection or infusion

The purpose of this study is to evaluate the outcome of medication discontinuation, the safety and effectiveness of re-initiating risperidone long acting injection (RLAI) in case of relapse (the return of a medical problem) of…

Trial name

NCT00378092

Testing

Oral risperidone, Risperidone Long-Acting Injection (RLAI)

Where

South Africa

Volunteers

33 people

Sponsor

Janssen Cilag N.V./S.A.